{"title":"ORTHOSTATIC HYPOTENSION AND FRAILTY SYNDROM","authors":"A. Ovchynnykova, Y. Trufanov, N. Svyrydova","doi":"10.33444/2414-0007.9.2.8-13","DOIUrl":null,"url":null,"abstract":"The objective of our research was to define the relationship between orthostatic hypotension (OH) and frailty syndrome (FS) in the older age group. \nMaterials and methods: the cross-sectional study involved patients of the older age group diagnosed with Parkinson's disease (PD) and cerebrovascular disease (CVD - chronic cerebral ischemia, chronic phase of ischemic stroke). All patients had comorbid OH. OH was established on the basis of a classical orthostatic test [10]. Each group included patients with different functional classes of OH (FC OH), from 1 to 4 [7]. The functional class of OH was determined using the orthostatic hypotension questionnaire (assessment of OH symptoms and the OH daily activity scale) [8]. All participants were assessed for the FS index based on the Edmonton Frail Scale [9]. \nResults: OH and FS has a close relationship, which is reflected in the direct correlation between OH and FS index (r=0.9). The higher FC OH, the more severe FS (p=0.001). The FC OH 1 corresponds to vulnerable, FC OH 2 to mild FS, FC OH 3 to moderate FS, and FC OH 4 to severe FS. \nConclusions: OH, having a close relationship with FS, may make an additional contribution to the reduction of the duration and quality of life of patients with FS and elderly patients [3, 5]. Unfortunately, currently, OH has not been included in the criteria of FS and is not evaluated in this cohort [9]. Therefore, we believe it is important to perform orthostatic testing in all patients with FS, which will prevent the occurrence of life-threatening complications caused by the persistence of OH [3, 5]. In the future, OH should be included in the criteria of FS.","PeriodicalId":135229,"journal":{"name":"East European Journal of Parkinson`s Disease and Movement Disorders","volume":" 43","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"East European Journal of Parkinson`s Disease and Movement Disorders","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33444/2414-0007.9.2.8-13","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The objective of our research was to define the relationship between orthostatic hypotension (OH) and frailty syndrome (FS) in the older age group.
Materials and methods: the cross-sectional study involved patients of the older age group diagnosed with Parkinson's disease (PD) and cerebrovascular disease (CVD - chronic cerebral ischemia, chronic phase of ischemic stroke). All patients had comorbid OH. OH was established on the basis of a classical orthostatic test [10]. Each group included patients with different functional classes of OH (FC OH), from 1 to 4 [7]. The functional class of OH was determined using the orthostatic hypotension questionnaire (assessment of OH symptoms and the OH daily activity scale) [8]. All participants were assessed for the FS index based on the Edmonton Frail Scale [9].
Results: OH and FS has a close relationship, which is reflected in the direct correlation between OH and FS index (r=0.9). The higher FC OH, the more severe FS (p=0.001). The FC OH 1 corresponds to vulnerable, FC OH 2 to mild FS, FC OH 3 to moderate FS, and FC OH 4 to severe FS.
Conclusions: OH, having a close relationship with FS, may make an additional contribution to the reduction of the duration and quality of life of patients with FS and elderly patients [3, 5]. Unfortunately, currently, OH has not been included in the criteria of FS and is not evaluated in this cohort [9]. Therefore, we believe it is important to perform orthostatic testing in all patients with FS, which will prevent the occurrence of life-threatening complications caused by the persistence of OH [3, 5]. In the future, OH should be included in the criteria of FS.